CST-3056
Asset
Centrally/peripherally acting adrenergic modulator to elevate blood pressure
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Neurogenic orthostatic hypotension
Phase 2, Active not recruiting, NCT07089043, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
Every asset’s record: target, stage, trials and the evidence behind it.